Particularly, TLR4 and its adaptor, myeloid differentiation primary response gene 88 (MyD88), were found to be essential for optimal antigen processing by inhibiting the fusion between phagosomes and lysosomes, thereby preventing the degradation of tumor antigens [78,79]. The gene discussed is TLR4; the disease is neoplasm.